Thursday Morning Pre-Market Insights: CHAU, IPCI, DSKY, QLGC

Direxion Daily CSI 300 China A Share Bull 2X Shares (NYSEARCA:CHAU) soared nearly 27% in pre-market trading on Thursday to $26.99 as China’s downward-spiraling stock exchange began showing  signs of stabilizing. The Chinese stock exchange began falling last week after a year of surging thanks to people borrowing money in order to buy stocks. China put security measures in place in an attempt to halt the impending crash. China’s stock exchange initially fell in trading on Thursday morning but then began to rebound, finally closing 6% up from where it opened.

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) shares jumped more than 10% in pre-market trading to $3.14 after the Toronto based pharmaceutical company received welcomed news from the FDA. Last month, the company indicated that the FDA was imposing new guidelines on certain strengths of Focalin, a drug produced by the company, which must be met before receiving final approval. However, yesterday the company indicated the FDA was rescinding these revised requirements. The already-approved Focalin capsules of 15mg and 30mg are not impacted. According to TipRanks, 2 analysts have given the stock bullish ratings in the past 3 months. The average 12-month price target for the stock is $7.50, marking more than 164% potential upside from where the stock is currently trading.

Wall Street

iDreamSky Technology Ltd (ADR) (NASDAQ:DSKY) shares increased more than 10% in pre-market trading to $10.60 since the Chinese stock market slightly rebounded. The company is the largest mobile game publishing platform in China but has been falling since the Chinese stock markets began to drop. Stocks rose today as a result of security measures implemented by government, such as the government’s decision to broker a deal in with 21 brokerages Chinese companies created a $19.4 billion fund to buy up shares of large companies. According to TipRanks, 2 analysts have given the stock bullish ratings in the past 3 months. The average 12-month price target on the stock is $13, marking a 35% potential upside from where the stock is currently trading.

1 2
View single page >> |

Disclosure: To see more, visit  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.